Inventor
MARCIN LAWRENCE R
US16 patents
⚠️ This page may combine multiple inventors who share the name “MARCIN LAWRENCE R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
13 patentsUS7300936B2Nov 27, 2007
α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
BRISTOL MYERS SQUIBB CO46 citations94
US7786122B2Aug 31, 2010
α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
BRISTOL MYERS SQUIBB CO12 citations82
US7105516B2Sep 12, 2006
Compounds for the treatment of premature ejaculation
BRISTOL MYERS SQUIBB CO15 citations82
US6777437B2Aug 17, 2004
Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
BRISTOL MYERS SQUIBB CO12 citations71
US7902218B2Mar 8, 2011
Substituted tetrahydroisoquinolines as β-secretase inhibitors
BRISTOL MYERS SQUIBB CO5 citations62
US7338974B2Mar 4, 2008
Macrocyclic diaminopropanes as beta-secretase inhibitors
BRISTOL MYERS SQUIBB CO6 citations62
US8349880B2Jan 8, 2013
Bicyclic compounds for the reduction of beta-amyloid production
BRISTOL MYERS SQUIBB CO4 citations61
US7084178B2Aug 1, 2006
Antiamyloid phenylsulfonamides: N-cycloalkylcarboxamides derivatives
BRISTOL MYERS SQUIBB CO2 citations60
US11639353B2May 2, 2023
Cyclobutanes- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitors
BRISTOL MYERS SQUIBB CO0 citations58
US11014922B2May 25, 2021
Cyclobutane- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitors
BRISTOL MYERS SQUIBB CO0 citations58
US8350084B2Jan 8, 2013
Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
BRISTOL MYERS SQUIBB CO0 citations52
US9738642B2Aug 22, 2017
Triazolopyridine ether derivatives and their use in neurological and pyschiatric disorders
BRISTOL MYERS SQUIBB CO1 citations51
US10112944B2Oct 30, 2018
Heterocyclic compounds useful as inhibitors of TNF
BRISTOL MYERS SQUIBB CO0 citations41